Key result
Atrial fibrillation in heart failure is linked to increased stroke risk, but not direct mortality.
Cohort (n=704,852)
Yes
In a large nationwide heart failure cohort, atrial fibrillation did not directly increase mortality risk independent of stroke, and stroke risk declined over time alongside increased direct-acting oral anticoagulant uptake, particularly in women.
Answers are grounded in this paper and cite their sources.
May inform stroke prevention in HF with AF; leaves open independent mortality effects.
BACKGROUND: While atrial fibrillation/flutter (AF) has been associated with increased risk of mortality in patients with heart failure (HF), it is unknown whether AF confers an increased risk on its own, i.e., not mediated through the increased risk of stroke. We aimed to investigate the age- and sex-specific prognostic impact of AF and stroke (alone and in combination) in patients with HF by using multistate modeling to account for events occurring during follow-up. Secondary aims were to investigate temporal trends in transition rates and in anticoagulant use in patients with AF and HF. METHODS: This was a Swedish nationwide cohort study that included adult patients with HF diagnosed between 2004 and 2025. We used multistate modeling to account for occurrences of AF and stroke both at baseline and during follow-up. With Poisson regression in generalized additive models, we assessed age- and sex-specific transition rates between the different disease states, and in a separate model including time period, we assessed temporal trends in transition rates. Finally, as oral anticoagulants influence stroke risk in patients with atrial fibrillation, we estimated temporal, sex-specific trends in their use. FINDINGS: We identified 704,852 patients (47% women) with HF, who were followed for a total of 2.9 million person-years. AF was associated with an increased risk of stroke but did not associate with an increased risk of death on its own. In the early study period, women, compared with men, were less likely to receive oral anticoagulants, but their use increased over time, more in women than in men. During the same period, there was a decline in stroke risk, with a greater absolute improvement in women than in men. CONCLUSIONS: In this study of patients with HF, AF was not associated with an elevated direct risk of mortality. Over time, the risk of stroke decreased in patients with HF and AF, temporally coinciding with a marked uptake of direct-acting oral anticoagulant (DOAC) use, with the largest improvement seen among women. FUNDING: This study was supported by unrestricted funding from Anders Wiklöf.
No takes yet. Share an insight, caveat, or question.
Sundström et al. (2026) conducted a cohort in Heart failure (n=704,852). Atrial fibrillation/flutter vs. No atrial fibrillation/flutter was evaluated on Age- and sex-specific transition rates for stroke and mortality. Atrial fibrillation increased stroke risk but not direct mortality risk in 704,852 heart failure patients over 2.9 million person-years.
Synapse has enriched 10 related papers. Consider them for comparative context: